GIV/Girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin

Journal of the American Society of Nephrology

Volumn 26, Issue 2, 2015, Pages 314-327

  Wang, Honghui ^a   Misaki, Taro ^a   Taupin, Vanessa ^a   Eguchi, Akiko ^b   Ghosh, Pradipta ^b   Farquhar, Marilyn G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G ALPHA INTERACTING VESICLE ASSOCIATED PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MEMBRANE PROTEIN; NEPHRIN; PROTEIN KINASE B; PROTEIN KINASE B BETA; PUROMYCIN AMINONUCLEOSIDE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; ACTIN BINDING PROTEIN; GALPHA-INTERACTING, VESICLE-ASSOCIATED PROTEIN, RAT; GNAI3 PROTEIN, RAT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; SIGNAL PEPTIDE; TARGET OF RAPAMYCIN KINASE; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; NEPHROSIS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL LINE; CHEMICALLY INDUCED; DISEASE MODEL; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MICE; MICROFILAMENT PROTEINS; NEPHROSIS; PHOSPHATIDYLINOSITOL 3-KINASES; PODOCYTES; PROTO-ONCOGENE PROTEINS C-AKT; PUROMYCIN AMINONUCLEOSIDE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84923931859     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013090985     Document Type: Article

References (70)

1. Greka A, Mundel P: Cell biology and pathology of podocytes. Annu Rev Physiol 74: 299-323, 2012
2. Pavenstädt H, Kriz W, Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev 83: 253-307, 2003
3. Garg P, Holzman LB: Podocytes: Gaining a foothold. Exp Cell Res 318: 955-963, 2012
4. Kerjaschki D: Caught flat-footed: Podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 108: 1583-1587, 2001
5. Reiser J, Sever S: Podocyte biology and pathogenesis of kidney disease. Annu Rev Med 64: 357-366, 2013
6. Kriz W: Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech 57: 189-195, 2002
7. Wiggins RC: The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int 71: 1205-1214, 2007
8. Shankland SJ: The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006
9. Huber TB, Hartleben B, Kim J, Schmidts M, Schermer B, Keil A, Egger L, Lecha RL, Borner C, Pavenstädt H, Shaw AS, Walz G, Benzing T: Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 23: 4917-4928, 2003
10. Huber TB, Benzing T: The slit diaphragm: A signaling platform to regulate podocyte function. Curr Opin Nephrol Hypertens 14: 211-216, 2005
11. Vasudevan KM, Garraway LA: AKT signaling in physiology and disease. Curr Top Microbiol Immunol 347: 105-133, 2010
12. Zhu J, Sun N, Aoudjit L, Li H, Kawachi H, Lemay S, Takano T: Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int 73: 556-566, 2008
13. Doné SC, Takemoto M, He L, Sun Y, Hultenby K, Betsholtz C, Tryggvason K: Nephrin is involved in podocyte maturation but not survival during glomerular development. Kidney Int 73: 697-704, 2008
14. Uchida K, Suzuki K, Iwamoto M, Kawachi H, Ohno M, Horita S, Nitta K: Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis. Kidney Int 73: 926-932, 2008
15. Kawachi H, Koike H, Kurihara H, Yaoita E, Orikasa M, Shia MA, Sakai T, Yamamoto T, Salant DJ, Shimizu F:Cloning of rat nephrin: Expression in developing glomeruli and in proteinuric states. Kidney Int 57: 1949-1961, 2000
16. Luimula P, Ahola H, Wang SX, Solin ML, Aaltonen P, Tikkanen I, Kerjaschki D, Holthöfer H:Nephrin in experimental glomerular disease. Kidney Int 58: 1461-1468, 2000
17. Hosoyamada M, Yan K, Nishibori Y, Takiue Y, Kudo A, Kawakami H, Shibasaki T, Endou H: Nephrin and podocin expression around the onset of puromycin aminonucleoside nephrosis. J Pharmacol Sci 97: 234-241, 2005
18. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H: The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome. Am J Nephrol 20: 175-179, 2000
19. Wen D, You L, Zhang Q, Zhang L, Gu Y, Hao CM, Chen J: Upregulation of nestin protects podocytes from apoptosis induced by puromycin aminonucleoside. Am J Nephrol 34: 423-434, 2011
20. Müller-Deile J, Worthmann K, Saleem M, Tossidou I, Haller H, Schiffer M: The balance of autocrine VEGF-A and VEGF-C determines podocyte survival. Am J Physiol Renal Physiol 297: F1656-F1667, 2009
21. Schrijvers BF, Flyvbjerg A, De Vriese AS: The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 65: 2003-2017, 2004
22. Tufro A, Veron D: VEGF and podocytes in diabetic nephropathy. Semin Nephrol 32: 385-393, 2012
23. Hohenstein B, Colin M, Foellmer C, Amann KU, Brekken RA, Daniel C, Hugo CP: Autocrine VEGF-VEGF-R loop on podocytes during glomerulonephritis in humans. Nephrol Dial Transplant 25: 3170-3180, 2010
24. Kanellis J, Levidiotis V, Khong T, Cox AJ, Stacker SA, Gilbert RE, Cooper ME, Power DA: A study of VEGF and its receptors in two rat models of proteinuria. Nephron, Physiol 96: 26-36, 2004
25. Bailey E, Bottomley MJ, Westwell S, Pringle JH, Furness PN, Feehally J, Brenchley PE, Harper SJ: Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. J Clin Pathol 52: 735-738, 1999
26. Bertuccio CA: Relevance of VEGF and nephrin expression in glomerular diseases. J Signal Transduct 2011: 718609, 2011
27. Veron D, Reidy KJ, Bertuccio C, Teichman J, Villegas G, Jimenez J, Shen W, Kopp JB, Thomas DB, Tufro A: Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney Int 77: 989-999, 2010
28. Ghosh P, Garcia-Marcos M, Farquhar MG: GIV/Girdin is a rheostat that fi ne-tunes growth factor signals during tumor progression. Cell Adhes Migr 5: 237-248, 2011
29. Ghosh P, Beas AO, Bornheimer SJ, Garcia-Marcos M, Forry EP, Johannson C, Ear J, Jung BH, Cabrera B, Carethers JM, Farquhar MG: A Galphai-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Mol Biol Cell 21: 2338-2354, 2010
30. Lin C, Ear J, Pavlova Y, Mittal Y, Kufareva I, Ghassemian M, Abagyan R, Garcia-Marcos M, Ghosh P: Tyrosine phosphorylation of the Gα-interacting protein GIV promotes activation of phosphoinositide 3-kinase during cell migration. Sci Signal 4: ra64, 2011
31. O'Hayre M, Degese MS, Gutkind JS: Novel insights into G protein and G protein-coupled receptor signaling in cancer. Curr Opin Cell Biol 27: 126-135, 2014
32. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, Shankland SJ: Inducible rodentmodels of acquired podocyte diseases. Am J Physiol Renal Physiol 296: F213-F229, 2009
33. Kerjaschki D, Sharkey DJ, Farquhar MG: Identification and characterization of podocalyxin - the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 98: 1591-1596, 1984
34. Fukasawa H, Bornheimer S, Kudlicka K, Farquhar MG: Slit diaphragms contain tight junction proteins. J Am Soc Nephrol 20: 1491-1503, 2009
35. Drenckhahn D, Franke RP: Ultrastructural organization of contractile and cytoskeletal proteins in glomerular podocytes of chicken, rat, and man. Lab Invest 59: 673-682, 1988
36. Canaud G, Bienaimé F, Viau A, Treins C, Baron W, Nguyen C, Burtin M, Berissi S, Giannakakis K, Muda AO, Zschiedrich S, Huber TB, Friedlander G, Legendre C, Pontoglio M, Pende M, Terzi F: AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat Med 19: 1288-1296, 2013
37. Boerries M, Grahammer F, Eiselein S, Buck M, Meyer C, Goedel M, Bechtel W, Zschiedrich S, Pfeifer D, Laloë D, Arrondel C, Gonc¸alves S, Krüger M, Harvey SJ, Busch H, Dengjel J, Huber TB: Molecular fingerprinting of the podocyte reveals novel gene and protein regulatory networks. Kidney Int 83: 1052-1064, 2013
38. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101, 2005
39. Laplante M, Sabatini DM: mTOR signaling in growth control and disease. Cell 149: 274-293, 2012
40. García-Martínez JM, Alessi DR: mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416: 375-385, 2008
41. Grahammer F, Wanner N, Huber TB:mTOR controls kidney epithelia in health and disease. Nephrol Dial Transplant 29[Suppl 1]: i9-i18, 2014
42. Enomoto A, Murakami H, Asai N, Morone N, Watanabe T, Kawai K, Murakumo Y, Usukura J, Kaibuchi K, Takahashi M: Akt/PKB regulates actin organization and cellmotility via Girdin/APE. DevCell 9: 389-402, 2005
43. Garcia-Marcos M, Ghosh P, Farquhar MG: GIV is a nonreceptor GEF for G alpha i with a unique motif that regulates Akt signaling. Proc Natl Acad Sci U S A 106: 3178-3183, 2009
44. Coleman DE, Lee E, Mixon MB, Linder ME, Berghuis AM, Gilman AG, Sprang SR: Crystallization and preliminary crystallographic studies of Gi alpha 1 and mutants of Gi alpha 1 in the GTP and GDP-bound states. J Mol Biol 238: 630-634, 1994
45. Lane JR, Henderson D, Powney B, Wise A, Rees S, Daniels D, Plumpton C, Kinghorn I, Milligan G: Antibodies that identify only the active conformation of G(i) family G protein alpha subunits. FASEB J 22: 1924-1932, 2008
46. López-Sánchez I, Garcia-Marcos M, Mittal Y, Aznar N, Farquhar MG, Ghosh P: Protein kinase C-theta (PKCu) phosphorylates and inhibits the guanine exchange factor, GIV/Girdin. Proc Natl Acad Sci U S A 110: 5510-5515, 2013
47. Ghosh P, Garcia-Marcos M, Bornheimer SJ, Farquhar MG: Activation of Galphai3 triggers cell migration via regulation of GIV. J Cell Biol 182: 381-393, 2008
48. Eguchi A, Meade BR, Chang YC, Fredrickson CT, Willert K, Puri N, Dowdy SF: Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein. Nat Biotechnol, 27: 567-571, 2009
49. Gödel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, Lu S, Debreczeni-Mór A, Lindenmeyer MT, Rastaldi MP, Hartleben G, Wiech T, Fornoni A, Nelson RG, Kretzler M, Wanke R, Pavenstädt H, Kerjaschki D, Cohen CD, Hall MN, Rüegg MA, Inoki K, Walz G, Huber TB: Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest 121: 2197-2209, 2011
50. Garcia-Marcos M, Ear J, Farquhar MG, Ghosh P: A GDI (AGS3) and a GEF (GIV) regulate autophagy by balancing G protein activity and growth factor signals. Mol Biol Cell 22: 673-686, 2011
51. Mittal Y, Pavlova Y, Garcia-Marcos M, Ghosh P: Src homology domain 2-containing protein-tyrosine phosphatase-1 (SHP-1) binds and dephosphorylates G(alpha)-interacting, vesicle-associated protein (GIV)/Girdin and attenuates the GIV-phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway. J Biol Chem 286: 32404-32415, 2011
52. Bertuccio C, Veron D, Aggarwal PK, Holzman L, Tufro A: Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes. J Biol Chem 286: 39933-39944, 2011
53. Takeda T, McQuistan T, Orlando RA, Farquhar MG: Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J Clin Invest 108: 289-301, 2001
54. Kitamura T, Asai N, Enomoto A, Maeda K, Kato T, Ishida M, Jiang P, Watanabe T, Usukura J, Kondo T, Costantini F, Murohara T, Takahashi M: Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat Cell Biol 10: 329-337, 2008
55. Ostalska-Nowicka D, Malinska A, Zabel M, Witkiewicz W, Nowicki M: Nephrotic syndrome unfavorable course correlates with down-regulation of podocyte vascular endothelial growth factor receptor (VEGFR)-2. Folia Histochem Cytobiol 49: 472-478, 2011
56. Korgaonkar SN, Feng X, Ross MD, Lu TC, D'Agati V, Iyengar R, Klotman PE, He JC: HIV-1 upregulates VEGF in podocytes. J Am Soc Nephrol 19: 877-883, 2008
57. Zhang QX, Nakhaei-Nejad M, Haddad G, Wang X, Loutzenhiser R, Murray AG: Glomerular endothelial PI3 kinase-α couples to VEGFR2, but is not required for eNOS activation. Am J Physiol Renal Physiol 301: F1242-F1250, 2011
58. Villegas G, Lange-Sperandio B, Tufro A: Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int 67: 449-457, 2005
59. Bussolati B, Deregibus MC, Fonsato V, Doublier S, Spatola T, Procida S, Di Carlo F, Camussi G: Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/AKT-signaling pathway. J Am Soc Nephrol 16: 1936-1947, 2005
60. Welsh GI, Hale LJ, Eremina V, Jeansson M, Maezawa Y, Lennon R, Pons DA, Owen RJ, Satchell SC, Miles MJ, Caunt CJ, McArdle CA, Pavenstädt H, Tavaré JM, Herzenberg AM, Kahn CR, Mathieson PW, Quaggin SE, Saleem MA, Coward RJ: Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab 12: 329-340, 2010
61. Le-Niculescu H, Niesman I, Fischer T, DeVries L, Farquhar MG: Identification and characterization of GIV, a novel Galpha i/s-interacting protein found on COPI, endoplasmic reticulum-Golgi transport vesicles. J Biol Chem 280: 22012-22020, 2005
62. Lehtonen S, Lehtonen E, Kudlicka K, Holthöfer H, Farquhar MG: Nephrin forms a complex with adherens junction proteins and CASK in podocytes and in Madin-Darby canine kidney cells expressing nephrin. Am J Pathol 165: 923-936, 2004
63. Orlando RA, Takeda T, Zak B, Schmieder S, Benoit VM, McQuistan T, Furthmayr H, Farquhar MG: The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interactions with ezrin. J Am Soc Nephrol 12: 1589-1598, 2001
64. Mundel P, Reiser J, Zúñiga Mejía Borja A, Pavenstädt H, Davidson GR, Kriz W, Zeller R: Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalizedmouse podocyte cell lines. Exp Cell Res 236: 248-258, 1997
65. McCaffery JM, Farquhar MG: Localization of GTPases by indirect immunofluorescence and immunoelectron microscopy. Methods Enzymol 257: 259-279, 1995
66. Miettinen A, Dekan G, Farquhar MG: Monoclonal antibodies against membrane proteins of the rat glomerulus. Immunochemical specificity and immuno fluorescence distribution of the antigens. Am J Pathol 137: 929-944, 1990
67. Garcia-Marcos M, Ghosh P, Ear J, Farquhar MG: A structural determinant that renders G alpha(i) sensitive to activation by GIV/girdin is required to promote cell migration. J Biol Chem 285: 12765-12777, 2010
68. Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, Vogelstein B, He TC: A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2: 1236-1247, 2007
69. Zhou Y, Kong X, Zhao P, Yang H, Chen L, Miao J, Zhang X, Yang J, Ding J, Guan Y: Peroxisomeproliferator-activated receptor-a is renoprotective in doxorubicin-induced glomerular injury. Kidney Int 79: 1302-1311, 2011
70. Iwasawa M, Miyazaki T, Nagase Y, Akiyama T, Kadono Y, Nakamura M, Oshima Y, Yasui T, Matsumoto T, Nakamura T, Kato S, Hennighausen L, Nakamura K, Tanaka S: The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice. J Clin Invest 119: 3149-3159, 2009